Antenatal inflammation and infection in chronic lung disease of prematurity

R E Miralles1, R Hodge, S Kotecha

  • 1Department of Child Health, University of Leicester, Leicester, UK.

Insights

Chronic lung disease (CLD) in preterm infants is linked to antenatal inflammation and infection. Further research using molecular techniques may clarify the role of Ureaplasma urealyticum in CLD pathogenesis.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Infectious Disease

Background:

  • Chronic lung disease (CLD) remains a significant cause of death and illness in extremely preterm infants despite advances in neonatal care.
  • Antenatal infection and inflammation are increasingly recognized as factors contributing to preterm birth and potentially increasing CLD susceptibility.
  • Pro-inflammatory cytokine exposure in the fetal lung is hypothesized to play a role in the development of CLD.

Purpose of the Study:

  • To explore the link between antenatal infection, intra-uterine inflammation, and the development of CLD in preterm infants.
  • To investigate the potential role of Ureaplasma urealyticum (Uu) as an initiator of intra-uterine inflammation and its association with CLD.
  • To review the current evidence on antibiotic interventions for mothers and preterm infants in relation to CLD outcomes.

Main Methods:

  • Literature review and synthesis of current research on antenatal infection, inflammation, and CLD.
  • Discussion of the potential role of Ureaplasma urealyticum (Uu) in the pathogenesis of CLD.
  • Evaluation of the efficacy of antibiotic treatments in mothers and neonates concerning CLD prevention and management.

Main Results:

  • Antenatal infection can trigger inflammation, leading to preterm labor and potentially increasing CLD risk in neonates.
  • Antibiotic use in mothers before delivery shows benefit for prolonged rupture of membranes but not for preterm labor with intact membranes.
  • The vertical transmission of Uu to preterm infants and its definitive role in causing CLD remain uncertain, with limited consistent benefits observed from postnatal antibiotic trials.

Conclusions:

  • CLD remains a critical issue for extremely preterm infants.
  • Molecular biology techniques, such as PCR, are expected to improve the detection of antenatal infections.
  • Enhanced detection methods will likely advance the understanding of CLD pathogenesis and inform future prevention strategies.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...